重视内脏静脉血栓形成的诊断和管理*

doi:10.3969/j.issn.1672-5069.2024.01.001

Abstract

Zhuge Yuzheng. Current knowledge and future perspectives of splanchnic vein thrombosis[J]. Journal of Practical Hepatology, 2024, 27(1): 1-2.

[1] TanR, Daneshmand A, Parys S, et al. Splanchnic venous thrombosis: Aetiologies and a review of the literature. ANZ J Surg, 2022, 92,2224-2228.
[2] Ponziani FR, Zocco MA, Garcovich M, et al. What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. World J Gastroenterol. 2012,18:5014-5020.
[3] Occo MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol, 2009,51:682-689.
[4] Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of PV thrombosis: a matched casecontrol study. Liver Int, 2018,38:94-101,e11.
[5] Valeriani E, Riva N, Nisio MD, et al. Splanchnic vein thrombosis: Current perspectives. Vasc Health Risk Manag,2019,15:449-461.
[6] Riva N, Donadini MP, Dentali F, et al. Clinical approach to splanchnic vein thrombosis: Risk factors and treatment. Thrombosis Res,2012,130:S1-S3.
[7] Baiges A, Procopet B, Silva-Junior G, et al. Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis. J Hepatol, 2023, 78(1):114-122.
[8] Thatipelli MR, McBane RD, Hodge DO, et al. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol, 2010, 8(2):200-205.
[9] Harding DJ, Perera MT, Chen F, et al. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol, 2015,21(22): 6769-6784.
[10] Caiano LM, Riva N, Carrier M, et al. Treatment of portal vein thrombosis: an updated narrative review. Minerva Med, 2021,112(6):713-725.
[11] Valeriani E, Nisio D, Riva M, et al. Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and Meta-analysis. Blood, 2021, 137:1233-1240.
[12] de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol, 2022, 77(1):271.

[1]	Yu Shanshan, Zhang Yeting, Wang Yuanpeng, et al. Changes of serum MMP-1, MMP-2, TIMP-1 and HIF-1α levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2024, 27(3): 329-332.
[2]	Peng Yujing, Guo Hang, Chen Junguang. Liver fibrosis assessment by US elastography in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2024, 27(3): 345-348.
[3]	Cao Yanfen, Zou Haoxuan, Xie Yan. Diagnostic performance of atherogenic index of plasma in predicting patients with metabolic-associated fatty liver disease from physical examination population [J]. Journal of Practical Hepatology, 2024, 27(3): 361-365.
[4]	Gao Ping, Gao Xuesong, Zhang Yijin, et al. Clinical feature of patients with hemochromatosis: An analysis of 8 cases [J]. Journal of Practical Hepatology, 2024, 27(3): 386-389.
[5]	Bai Ping, Wang Han, Liu Rui, et al. Qualitative diagnosis of intrahepatic space-occupying lesions by multi-slice spiral CT and enhanced liver acquisition with volume acceleration [J]. Journal of Practical Hepatology, 2024, 27(3): 422-425.
[6]	Mei Wenjuan, Li Xin, Zhang Haoyue. Differentiation of hepatocellular carcinoma from metastatic liver cancer by time-intensity curve related parameters of contrast-enhanced ultrasonography [J]. Journal of Practical Hepatology, 2024, 27(3): 430-433.
[7]	Wang Qianwen, Hu Linlin, Xu Yunjun. Diagnostic performance of serum SPINK1 levels for hepatocellular carcinoma in patients with hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2024, 27(3): 442-445.
[8]	Shi Yu, Meng Linghui, Wang Luma. CT enhancement scan imaging feature of cholangiocellular carcinoma: An analysis of 18 cases [J]. Journal of Practical Hepatology, 2024, 27(3): 446-449.
[9]	Chen Ai’e, Peng Xiangqian, Chen Lina. Choice of open orlaparoscopic cholecystectomy under guidance of preoperative multi-slice spiral CT scan in patients with gallstones and cholecystitis [J]. Journal of Practical Hepatology, 2024, 27(3): 466-469.
[10]	Xu Jinghang, Yu Yanyan, Xu Xiaoyuan. Liver cirrhosis: Current state of the art [J]. Journal of Practical Hepatology, 2024, 27(2): 161-164.
[11]	Guo Meng, Guo Qi, Zhang Feng. Evaluation of hepatic steatosis by controlled attenuation parameter of ultrasonic transient elastography in patients with nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2024, 27(2): 189-192.
[12]	Li Min, Zhang Li, Zeng Ai, et al.. Liver fibrosis in patients with diabetes mellitus type 2 and non-alcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2024, 27(2): 193-197.
[13]	Zheng Bo, Halida.Xiaerfuhazi, Tan Li. Changes of serum HIF-1α, HMGB1 and adiponectin levels in patients with non-alcoholic fatty liver diseases and their correlation to carotid atherosclerosis [J]. Journal of Practical Hepatology, 2024, 27(2): 198-201.
[14]	Tong Jing, Zhang Keli, Li Changping. Diagnostic performance of serum proneurotensin level and micro RNA load in patients with nonalcoholic steatohepatitis [J]. Journal of Practical Hepatology, 2024, 27(2): 202-205.
[15]	Zhu Chunfen, Ren Chunlin, Guo Xia. Elevated serum NT-ProBNP and TnI levels occurs before abnormal electrocardiogram manifestations in patients with cirrhotic cardiomyopathy [J]. Journal of Practical Hepatology, 2024, 27(2): 242-245.

Current knowledge and future perspectives of splanchnic vein thrombosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments